Concepedia

Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review

Rogelio González‐González, Sandra López‐Verdín, Jesús Lavalle‐Carrasco, Nelly Molina‐Frechero, Mario Alberto Isiordia‐Espinoza, Ramón Gil Carreón-Burciaga, Ronell Bologna‐Molina

World Journal of Clinical Oncology · 2019 · 54 citations · 20 references

DOIFull text

Open access

Abstract

The identification of BRAF V600E and additional mutations as an aid in targeted therapies has been a breakthrough in alternative treatments of ameloblastomas where surgical treatments are contraindicated.

References

20

Identification of recurrent SMO and BRAF mutations in ameloblastomas

Robert T. Sweeney, Andrew C. McClary, Benjamin R. Myers et al. · Nature Genetics · 2014 · 347 citations · Full text

, , +3

A critical appraisal tool for library and information research

Lindsay Glynn · Library Hi Tech · 2006 · 341 citations

, , +13

Activating alleles of JAK3 in acute megakaryoblastic leukemia

Denise K. Walters, Thomas Mercher, Ting-Lei Gu et al. · Cancer Cell · 2006 · 313 citations

, , +5

High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma

Kari J. Kurppa, Javier Catón, Peter R. Morgan et al. · The Journal of Pathology · 2013 · 296 citations · Full text

, , +13

Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Noah A. Brown, Delphine Rolland, Jonathan B. McHugh et al. · Clinical Cancer Research · 2014 · 287 citations · Full text